Cargando…

Transcription/Replication Conflicts in Tumorigenesis and Their Potential Role as Novel Therapeutic Targets in Multiple Myeloma

SIMPLE SUMMARY: Multiple myeloma is a hematologic cancer characterized by the accumulation of malignant plasma cells in the bone marrow. It remains a mostly incurable disease due to the inability to overcome refractory disease and drug-resistant relapse. Oncogenic transformation of PC in multiple my...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dutrieux, Laure, Lin, Yea-Lih, Lutzmann, Malik, Rodriguez, Raphaël, Cogné, Michel, Pasero, Philippe, Moreaux, Jérôme
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345052/ https://www.ncbi.nlm.nih.gov/pubmed/34359660 http://dx.doi.org/10.3390/cancers13153755

Ejemplares similares

The BLM helicase is a new therapeutic target in multiple myeloma involved in replication stress survival and drug resistance
por: Ovejero, Sara, et al.
Publicado: (2022)

Topoisomerase I prevents transcription-replication conflicts at transcription termination sites
por: Liu, Yaqun, et al.
Publicado: (2020)

Interference Between DNA Replication and Transcription as a Cause of Genomic Instability
por: Lin, Yea-Lih, et al.
Publicado: (2012)

Kinome expression profiling to target new therapeutic avenues in multiple myeloma
por: de Boussac, Hugues, et al.
Publicado: (2020)

A DNA repair pathway score predicts survival in human multiple myeloma: the potential for therapeutic strategy
por: Kassambara, Alboukadel, et al.
Publicado: (2014)

Mec1, INO80, and the PAF1 complex cooperate to limit transcription replication conflicts through RNAPII removal during replication stress
por: Poli, Jérôme, et al.
Publicado: (2016)

TDP-43 dysfunction results in R-loop accumulation and DNA replication defects
por: Wood, Matthew, et al.
Publicado: (2020)

DDK Has a Primary Role in Processing Stalled Replication Forks to Initiate Downstream Checkpoint Signaling
por: Sasi, Nanda Kumar, et al.
Publicado: (2018)

Overexpression of Claspin and Timeless protects cancer cells from replication stress in a checkpoint-independent manner
por: Bianco, Julien N., et al.
Publicado: (2019)

RNA-sequencing data-driven dissection of human plasma cell differentiation reveals new potential transcription regulators
por: Kassambara, Alboukadel, et al.
Publicado: (2021)

Topoisomerase 1 prevents replication stress at R-loop-enriched transcription termination sites
por: Promonet, Alexy, et al.
Publicado: (2020)

Targeting Cellular Iron Homeostasis with Ironomycin in Diffuse Large B-cell Lymphoma
por: Devin, Julie, et al.
Publicado: (2022)

RECQ1 helicase is involved in replication stress survival and drug resistance in multiple myeloma
por: Viziteu, E, et al.
Publicado: (2017)

RECQ helicases are deregulated in hematological malignancies in association with a prognostic value
por: Viziteu, Elena, et al.
Publicado: (2016)

Consequences and Resolution of Transcription–Replication Conflicts
por: Lalonde, Maxime, et al.
Publicado: (2021)

SNaPshot as a Valuable Option for the Identification of Mutations in Myeloma
por: Moreaux, Jerome
Publicado: (2014)

Co-directional replication-transcription conflicts lead to replication restart
por: Merrikh, Houra, et al.
Publicado: (2011)

Multi-omics tumor profiling technologies to develop precision medicine in multiple myeloma
por: Ovejero, Sara, et al.
Publicado: (2021)

A novel mechanism for the prevention of transcription replication conflicts
por: Canal, Berta, et al.
Publicado: (2018)

The enigmatic role of Mfd in replication-transcription conflicts in bacteria
por: Ragheb, Mark, et al.
Publicado: (2019)

EXD2 Protects Stressed Replication Forks and Is Required for Cell Viability in the Absence of BRCA1/2
por: Nieminuszczy, Jadwiga, et al.
Publicado: (2019)

Residual malignant and normal plasma cells shortly after high dose melphalan and stem cell transplantation. Highlight of a putative therapeutic window in Multiple Myeloma?
por: Caraux, Anouk, et al.
Publicado: (2012)

The replication timing program in the hands of two HDACs
por: Yoshida, Kazumasa, et al.
Publicado: (2014)

The roles of replication-transcription conflict in mutagenesis and evolution of genome organization
por: Schroeder, Jeremy W., et al.
Publicado: (2020)

Coordinating transcription and replication to mitigate their conflicts in early Drosophila embryos
por: Cho, Chun-Yi, et al.
Publicado: (2022)

Small molecule targeting of transcription-replication conflict for selective chemotherapy
por: Gu, Long, et al.
Publicado: (2023)

Direct visualization of transcription-replication conflicts reveals post-replicative DNA:RNA hybrids
por: Stoy, Henriette, et al.
Publicado: (2023)

The Replication Stress Response on a Narrow Path Between Genomic Instability and Inflammation
por: Técher, Hervé, et al.
Publicado: (2021)

Treatment May Be Harmful: Mechanisms/Prediction/Prevention of Drug-Induced DNA Damage and Repair in Multiple Myeloma
por: Gourzones, Claire, et al.
Publicado: (2019)

Overexpression of the Fork Protection Complex: a strategy to tolerate oncogene-induced replication stress in cancer cells
por: Pasero, Philippe, et al.
Publicado: (2019)

Topological stress is responsible for the detrimental outcomes of head-on replication-transcription conflicts
por: Lang, Kevin S., et al.
Publicado: (2021)

Drug metabolism and clearance system in tumor cells of patients with multiple myeloma
por: Hassen, Wafa, et al.
Publicado: (2014)

Top1 and Top2 promote replication fork arrest at a programmed pause site
por: Larcher, Mélanie V., et al.
Publicado: (2020)

Senataxin resolves RNA:DNA hybrids forming at DNA double-strand breaks to prevent translocations
por: Cohen, Sarah, et al.
Publicado: (2018)

Characterization of human FCRL4-positive B cells
por: Jourdan, Michel, et al.
Publicado: (2017)

The Role of Replication Clamp-Loader Protein HolC of Escherichia coli in Overcoming Replication/Transcription Conflicts
por: Cooper, Deani L., et al.
Publicado: (2021)

PRC2 targeting is a therapeutic strategy for EZ score defined high-risk multiple myeloma patients and overcome resistance to IMiDs
por: Herviou, Laurie, et al.
Publicado: (2018)

Antioxidant Defenses Confer Resistance to High Dose Melphalan in Multiple Myeloma Cells
por: Gourzones, Claire, et al.
Publicado: (2019)

Editorial: Transcriptional control in normal and malignant B-lymphocytes
por: Moreaux, Jerome, et al.
Publicado: (2023)

TRAIP resolves DNA replication-transcription conflicts during the S-phase of unperturbed cells
por: Scaramuzza, Shaun, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_khqld5up3of22f1ljfscca6hle